Cardio Price Fair Value from 2010 to 2024

CDIOW Stock  USD 0.04  0  9.24%   
Cardio Diagnostics Price Fair Value yearly trend continues to be fairly stable with very little volatility. Price Fair Value will likely drop to 10.14 in 2024. During the period from 2010 to 2024, Cardio Diagnostics Price Fair Value regression line of quarterly data had mean square error of  219,800 and geometric mean of  343.13. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
10.67770694
Current Value
10.14
Quarterly Volatility
704.81077061
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 117.2 K or Selling General Administrative of 7.3 M, as well as many indicators such as Price To Sales Ratio of 1.8 K, Dividend Yield of 0.0 or PTB Ratio of 10.14. Cardio financial statements analysis is a perfect complement when working with Cardio Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Cardio Diagnostics Correlation against competitors.

Latest Cardio Diagnostics' Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Cardio Diagnostics Holdings over the last few years. It is Cardio Diagnostics' Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
       Timeline  

Cardio Price Fair Value Regression Statistics

Arithmetic Mean1,137
Geometric Mean343.13
Coefficient Of Variation61.98
Mean Deviation602.22
Median1,548
Standard Deviation704.81
Sample Variance496,758
Range1.5K
R-Value(0.77)
Mean Square Error219,800
R-Squared0.59
Significance0.0008
Slope(120.97)
Total Sum of Squares7M

Cardio Price Fair Value History

2024 10.14
2023 10.68
2022 0.76
2021 10.69

About Cardio Diagnostics Financial Statements

Cardio Diagnostics investors use historical fundamental indicators, such as Cardio Diagnostics' Price Fair Value, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Fair Value 10.68  10.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.